Clinical trials
Hyperlipidemias trials in Malaysia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 2 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Isa Naina Mohamed | 1 |
| Malaysia Palm Oil Board | 1 |
| Ministry of Health, Malaysia | 1 |
| National University of Malaysia | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Universiti Kebangsaan Malaysia Medical Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 13 |
| Hypercholesterolemia | 6 |
| Cardiovascular Diseases | 4 |
| Dyslipidemias | 4 |
| Homozygous Familial Hypercholesterolemia | 3 |
| Hypertension | 3 |
| Aortic Valve Stenosis | 2 |
| Heart Failure | 2 |
| Hyperlipoproteinemia Type II | 2 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.